Showing results (491-500 of 688) with videos related to

Sort By:
Pageof 69
Tijdschrift Voor Psychiatrie|October 13, 2009
[Psychiatric symptoms in systemic lupus erythematosus]C Boersma, A J J M de Groot, J G F M Hovens, et al.
Arthritis and Rheumatism|February 24, 2010
Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluidHans U Scherer, Diane van der Woude, Andreea Ioan-Facsinay, et al.
Annals of the Rheumatic Diseases|March 13, 2010
The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritisKlaus P Machold, Robert Landewé, Josef S Smolen, et al.
Arthritis and Rheumatism|August 1, 2009
Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritisMichael P M van der Linden, Diane van der Woude, Andreea Ioan-Facsinay, et al.
Annals of the Rheumatic Diseases|April 26, 2012
Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-upM van den Broek, L Dirven, J K de Vries-Bouwstra, et al.
Arthritis Research & Therapy|September 26, 2014
Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritisIris M Markusse, Jeska K de Vries-Bouwstra, K Huub Han, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 13, 2015
Association of valine and leucine at HLA-DRB1 position 11 with radiographic progression in rheumatoid arthritis, independent of the shared epitope alleles but not independent of anti-citrullinated protein antibodiesH W van Steenbergen, S Raychaudhuri, L Rodríguez-Rodríguez, et al.
Annals of the Rheumatic Diseases|November 12, 2010
Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigensP Suwannalai, H U Scherer, D van der Woude, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2026
Baseline interleukin-10 levels as a predictive biomarker for achieving clinical response with abatacept in disease-modifying antirheumatic drug-naive and anticitrullinated protein antibody-positive patients with early rheumatoid arthritisJinqi Liu, Yicong Li, Kai Fu, et al.
Arthritis and Rheumatism|April 21, 2011
The interaction between HLA shared epitope alleles and smoking and its contribution to autoimmunity against several citrullinated antigensAnnemiek Willemze, Diane van der Woude, Wendimagegn Ghidey, et al.
Pageof 69